ECA
CME icon

Elevate Capital Advisors’s CME Group CME Stock Holding History

Elevate Capital Advisors’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26M Sell
7,650
-2,050
-21% -$609K 1.46% 23
2025
Q4 		$2.65M Buy
9,700
+1,181
+14% +$321K 1.75% 20
2025
Q3 		$2.3M Buy
8,519
+3,919
+85% +$1.07M 1.6% 26
2025
Q2 		$1.27M Sell
4,600
-808
-15% -$220K 1.01% 49
2025
Q1 		$1.43M Sell
5,408
-289
-5% -$71.3K 1.33% 38
2024
Q4 		$1.32M Buy
+5,697
New +$1.31M 1.17% 37

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Elevate Capital Advisors's CME Position: Q1 2026 in Review

Elevate Capital Advisors reduced its CME Group (CME) stake by 21% in Q1 2026, selling an estimated $609K and leaving 7,650 shares worth $2.26M. The position accounts for 1.46% of the portfolio, ranked #23.

Elevate Capital Advisors first reported a position in CME in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.65M in Q4 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Elevate Capital Advisors held 7,650 shares of CME Group worth $2.26M as of Q1 2026.
  • Elevate Capital Advisors sold 2,050 CME Group shares in Q1 2026, an estimated $609K.
  • CME Group made up 1.46% of Elevate Capital Advisors's portfolio in Q1 2026, its #23 holding.
  • Elevate Capital Advisors first reported a position in CME Group in Q4 2024 and has held it in 6 quarters since.
  • Elevate Capital Advisors's CME Group position peaked at $2.65M in Q4 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Elevate Capital Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.